related documents
- A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS Conference Paper
- A multicenter phase II study of lapatinib in recurrent or metastatic adenoid cystic (ACC) and non-ACC malignant tumors of the salivary glands (MSGT) Conference Paper
- A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (ADV RCC) Conference Paper
- A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC) Conference Paper
- Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer Conference Paper
- Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck Conference Paper
- Zoledronic acid may improve survival in lung cancer patients with high baseline bone marker levels Conference Paper